Otros idiomas CEL-SCI Corporation

Acciones

CVM

US1508376076

Diferido Nyse Otros sitios de cotización 16:56:29 30/04/2024			Varia. Cinco días.	Varia. 1 de enero.
1,43 ^USD	+1,42 %		-2,72 %	-47,43 %

23/04	CEL-SCI Corporation nombra a Mario Gobbo miembro de su consejo de administración	CI
14/02	CEL-SCI Corporation comunica los resultados del primer trimestre finalizado el 31 de diciembre de 2023	CI

Otros idiomas

Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!

Inscripción 100% Gratuita

CEL-SCI Appoints Mario Gobbo to Its Board of Directors	23/04
CEL-SCI Corporation Appoints Mario Gobbo as Board of Directors	23/04
CEL-SCI’s LEAPS Vaccine Offers Promising New Paradigm to Treat Rheumatoid Arthritis: Published in Frontiers in Immunology	19/03
CEL-SCI Corporation Issues Letter to Shareholders	06/03
CEL-SCI Corporation Reports First Quarter Fiscal 2024 Financial Results	15/02
Cel-Sci: Fiscal Q1 Earnings Snapshot	14/02
CEL-SCI Corporation Reports Earnings Results for the First Quarter Ended December 31, 2023	14/02
CEL-SCI Corporation (von First Berlin Equity Research GmbH...	14/02
Cel-Sci Closes $7.8 Million Share Offering	13/02
CEL-SCI Announces Closing of $7.75 Million Public Offering of Common Stock	13/02
CEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stock	12/02
Health Care Slips on Rotation to High-Risk Sectors -- Health Care Roundup	10/02
Cel-Sci Prices $7.8 Million Public Offering of Common Shares	09/02
CEL-SCI Announces Pricing of $7.75 Million Public Offering of Common Stock	09/02
CEL-SCI Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head and Neck Cancer Drug	07/02
CEL-SCI Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head & Neck Cancer Drug	06/02
CEL-SCI Corporation Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head & Neck Cancer Drug	06/02
European Medicines Agency Grants CEL-SCI a Waiver of Strict Pediatric Requirements, Clearing the Path towards Marketing Authorization for Multikine	01/02
Sector Update: Health Care Stocks Mixed Late Wednesday Afternoon	31/01
Sector Update: Health Care Stocks Gain in Afternoon Trading	31/01

No hay resultados para esta búsqueda

Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Otros idiomas CEL-SCI Corporation

Acciones

CVM

US1508376076

Otros idiomas

Filtros